Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
12/08/2009 | CA2415486C Pyramidine derivatives |
12/08/2009 | CA2383054C Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation |
12/08/2009 | CA2374898C Pyrazinyl-piperazine compounds, their use and preparation |
12/08/2009 | CA2302496C Urinary incontinence therapy |
12/08/2009 | CA2292846C Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them |
12/03/2009 | WO2009145831A1 Treatment of the idiopathic nephrotic syndrome spectrum diseases using basiliximab |
12/03/2009 | WO2009126844A3 Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
12/03/2009 | WO2009086426A3 Soluble epoxide hydrolase inhibitors for the treatment of endothelial dysfunction |
12/03/2009 | US20090298883 N-piperidinyl acetamide derivatives as calcium channel blockers |
12/03/2009 | US20090297635 Biodisintegrable Medical Devices |
12/03/2009 | US20090297483 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
12/03/2009 | DE202008015620U1 Phosphatbinder Phosphate binders |
12/02/2009 | EP2128265A1 Method for glycosylation of flavonoid |
12/02/2009 | EP2128163A1 Spiro-ring compound |
12/02/2009 | EP2128148A1 Compound, alpha 1 adrenaline receptor antagonist, and composition |
12/02/2009 | EP2127645A1 Pharmaceutical agent for prevention and/or treatment of lower urinary tract symptom |
12/02/2009 | EP2125859A2 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
12/02/2009 | EP2125787A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof |
12/02/2009 | EP2125717A2 Deuterated derivatives of silodosin as alpha ia-adrenoreceptor antagonists |
12/02/2009 | EP2125021A1 Combination therapy of lower urinary tract disorders with 2 ligands and nsaids |
12/02/2009 | EP2124956A1 Use of 10-[(3r)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine for the preparation of a drug having a selective inhibition of muscarinic m1, m2 and m3 receptors |
12/02/2009 | EP1248804B2 Recombinant antibodies to human interleukin-1 beta |
12/02/2009 | CN101595131A Methods of reducing phosphate absorption |
12/02/2009 | CN101595088A Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
12/02/2009 | CN101591597A Liver and kidney tonifying wine |
12/02/2009 | CN101590213A Chinese medicinal decoction for treating lithiasis and preparation method thereof |
12/02/2009 | CN101590204A Chemical method of chemical protein carrier of plant Chinese herb medicine and carrier chemical protein |
12/02/2009 | CN101590203A Chinese medicament for curing infantile enuresis |
12/02/2009 | CN101590194A Traditional Chinese medicine for treating urinary calculi |
12/02/2009 | CN101590190A Traditional Chinese medicine composition for treating toxuria |
12/02/2009 | CN101590135A Chinese medicament for treating urinary calculus and gallstone |
12/02/2009 | CN101590134A Total triterpene of garden burnet root with anti-inflammatory and analgesic effects and preparation method thereof |
12/02/2009 | CN101590126A TCM composite for treating benign prostatic hyperplasia |
12/02/2009 | CN101590117A Compound longhairy antenoron herb preparation for treating kidney swellings of animals and preparation method thereof |
12/02/2009 | CN101590059A Medicine combination containing naftopidil and dutasteride |
12/02/2009 | CN101590048A Pharmaceutical composition containing amlodipine and dutasteride |
12/02/2009 | CN101590047A Pharmaceutical composition containing amlodipine and epristeride |
12/02/2009 | CN101590046A Medicine combination containing amlodipine besy and finasteride |
12/02/2009 | CN101590045A Medicine combination containing amlodipine besy and naftopidil and application thereof |
12/02/2009 | CN101589800A Manufacture method of kidney-invigorating beverage |
12/02/2009 | CN100564375C (3Z) -3-(2,3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
12/01/2009 | US7626012 Nucleic acids encoding monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
12/01/2009 | US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
12/01/2009 | US7625934 Metalloproteinase inhibitors |
12/01/2009 | US7625929 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
12/01/2009 | US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
12/01/2009 | US7625887 e.g. 2-[3,5-trans-5-(3-aminophenyl)-7-chloro-1-neopentyl-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-N-(2-fluorobenzyl)acetamide; G-protein-coupled receptor (TGR5) agonist; central nervous system diseases; antiinflammatory agent; learning enhancement; angina pectoris, arrhythmia, bronchial asthma |
12/01/2009 | US7625713 Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide |
12/01/2009 | CA2461100C 4-imidazolin-2-one compounds |
12/01/2009 | CA2432121C Nitric oxide synthase inhibitor phosphate salt |
11/26/2009 | WO2009143021A1 Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same |
11/26/2009 | WO2009142321A1 Novel thiophenediamine derivative having urea structure |
11/26/2009 | WO2009142195A1 Agent for induction/maintenance of remission |
11/26/2009 | WO2009114520A3 Compositions for treatment with metallopeptidases, methods of making and using the same |
11/26/2009 | WO2009102945A3 Method for treating stress urinary incontinence and symptomatic pelvic relaxation |
11/26/2009 | WO2008150477A3 N-acetyl mannosamine as a therapeutic agent |
11/26/2009 | US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity |
11/26/2009 | US20090291953 Pharmaceutical salts of reboxetine |
11/26/2009 | US20090291924 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
11/26/2009 | US20090291098 Immunogenic LHRH compositions and methods relating thereto |
11/26/2009 | CA2724592A1 Agent for maintenance of induced remission |
11/26/2009 | CA2724357A1 Novel thiophenediamine derivative having urea structure |
11/25/2009 | EP2123752A2 Novel nucleic acid |
11/25/2009 | EP2123652A1 Heterocyclic compound |
11/25/2009 | EP2123644A1 Benzoxazepine derivatives and use thereof |
11/25/2009 | EP2123303A1 Ameliorating agent for insulin resistance |
11/25/2009 | EP2123301A1 Therapeutic agent for urinary tract disease |
11/25/2009 | EP2123273A1 Therapeutic agent for urinary excretion disorder |
11/25/2009 | EP2123270A1 Iron metabolism-improving agent |
11/25/2009 | EP2123171A1 Feed mixture |
11/25/2009 | EP2120946A1 Pharmaceutical composition comprising nicotinamide or nicotinic acid |
11/25/2009 | EP2120918A2 Pharmaceutical composition for treating incontinence |
11/25/2009 | EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors |
11/25/2009 | EP1242385B1 Cytokine, especially tnf-alpha, inhibitors |
11/25/2009 | EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity |
11/25/2009 | CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/25/2009 | CN101584843A Chinese drugs for curing lithiasis |
11/25/2009 | CN101584840A Chinese medicament for treating long-term uncured urinary calculus |
11/25/2009 | CN101584825A Health protection tea for treating chronic nephritis |
11/25/2009 | CN101584819A Chinese medicament for treating acute prostatitis |
11/25/2009 | CN101584818A Traditional Chinese medicine for treating urinary tract infection |
11/25/2009 | CN101584817A Traditional Chinese medicine for treating urinary calculus and tumor |
11/25/2009 | CN101584807A Application of traditional Chinese medicine composition in preparing medicament of insulin sensitizer |
11/25/2009 | CN101584800A Traditional Chinese medicine for nourishing kidney |
11/25/2009 | CN101584786A Chinese materia medica preparation for treating chronic renal insufficiency |
11/25/2009 | CN101584782A Chinese medicament for treating nocturnal enuresis |
11/25/2009 | CN101584779A Traditional Chinese medicine for removing calculus |
11/25/2009 | CN101584764A Medicinal dripping pill for treating chronic cystitis |
11/25/2009 | CN101584758A Medicine composition for treating kidney deficiency |
11/25/2009 | CN101584757A Traditional Chinese medicine composition for treating diabetic nephropathy |
11/25/2009 | CN101584753A New medical use of Shenshitong preparation |
11/25/2009 | CN101584735A Pharmaceutical composition for preventing and treating chicken bursal disease and nephrotic bronchitis and preparation method thereof |
11/25/2009 | CN101584700A Pharmaceutical composition |
11/25/2009 | CN101584459A Health-protection tea for treating kidney diseases and Yang deficiency |
11/25/2009 | CN101584372A Health-care tea for warming kidney and strengthening spleen for middle-old aged people |
11/24/2009 | US7622487 Piperidine derivative, process for producing the same, and use |
11/24/2009 | CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
11/24/2009 | CA2475712C Nicotinamide derivatives useful as pde4 inhibitors |
11/24/2009 | CA2434381C Naphthostyrils |
11/24/2009 | CA2247389C Agent for treatment of bladder troubles |